RxDoctor Payments Data

Mykola Bartkiw, DO

Orthopaedic Surgery · Auburn Hills, MINPI 1861619736

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (51.7%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 34 manufacturers reported payments, led by Medical Device Business Services, Inc. at 54.3% of the total. Reporting peaked in 2024 at $5,479 and has fallen 91.4% since, to $469 in 2025.

$9,000in general payments, 2019–2025

Across 115 payments — averaging $78.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$5K
  • Acumed LLC$767
  • Johnson & Johnson$319
  • Pinnacle, Inc$299
  • Ferring Pharmaceuticals Inc.$281
  • Amgen$248
  • plus $2K from 28 others

What the payments were for

  • Consulting fees$4,65052%
  • Travel & lodging$7508%
  • Food & beverage$3,52339%
  • Education$771%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,000 in reported general payments places this provider in the 70th percentile of 829 orthopaedic surgery providers in Michigan.

See all orthopaedic surgery providers in Michigan →

Medicare billing

Part B allowed, 2024
$178,288
Medicare patients
321
Services billed
1,834

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dexamethasone Sodium Phosphate42$800
Diclofenac Sodium24$420

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Auburn Hills

See the full list for Michigan →

Where these figures come from

Is this you, or does something look wrong? →